Raymond Debbane holds 675000 Yarrow Bioscience shares, representing 7.2% of the class, under a passive ownership position. The stated certification says the securities were not acquired or held to change or influence control of Yarrow Bioscience, giving investors a defined ownership percentage and a non-control purpose.

Key Highlights

  • The securities are common stock with a $0.0001 par value.
  • The stated purpose excludes seeking to change or influence control of Yarrow Bioscience.
  • Raymond Debbane signed the related agreements on September 17, 2026.

Raymond Debbane holds 675,000 shares of Yarrow Bioscience, Inc. (NASDAQ: YARW), equal to 7.2% of the class. The ownership date is September 11, 2026. The stated purpose excludes seeking to change or influence control of Yarrow Bioscience.

Debbane’s Yarrow Position

The securities are common stock with a $0.0001 par value. Raymond Debbane is listed among the reporting persons connected with the Yarrow Bioscience position. The ownership percentage shown for him is 7.2%. The certification says the securities were not acquired or held for the purpose or effect of changing or influencing control of Yarrow Bioscience.

Control Chain Behind Stake

Invus Public Equities, L.P. is identified alongside Invus Public Equities Advisors, LLC, Invus Global Management, LLC and Siren, L.L.C. The stated control structure runs through those entities, with Invus Public Equities Advisors serving as general partner of Invus Public Equities. Avicenna Life Sci Master Fund LP is listed with Avicenna Life Sci Master GP LLC, while Ulys, L.L.C. is identified as controlling Avicenna GP. Raymond Debbane is described as controlling Siren and Ulys. As of September 14, 2026, each reporting person may be deemed the beneficial owner of the percentage shown on that person’s cover page.

Passive Ownership Certification

Raymond Debbane signed for the listed entities and in his own name. The related joint filing agreement covers the statement concerning Yarrow Bioscience and any amendments signed by the participating parties. The agreement is dated September 17, 2026.